199 related articles for article (PubMed ID: 6311491)
21. [Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
Monteil H; Peladan F; Zinsius M
Presse Med; 1984 Mar; 13(13):780-4. PubMed ID: 6324160
[TBL] [Abstract][Full Text] [Related]
22. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Mintz L; Drew WL
Antimicrob Agents Chemother; 1981 Feb; 19(2):332-4. PubMed ID: 6289731
[TBL] [Abstract][Full Text] [Related]
23. Effects of inducible beta-lactamase and antimicrobial resistance upon the activity of newer beta-lactam antibiotics against Pseudomonas aeruginosa.
Hoffman TA; Cleary TJ; Bercuson DH
J Antibiot (Tokyo); 1981 Oct; 34(10):1334-40. PubMed ID: 6796556
[TBL] [Abstract][Full Text] [Related]
24. Synergism of azlocillin, mezlocillin, piperacillin in combination with tobramycin against Klebsiella and Pseudomonas.
Downs JT; Andriole VT; Ryan JL
Yale J Biol Med; 1986; 59(1):11-6. PubMed ID: 3634545
[TBL] [Abstract][Full Text] [Related]
25. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Corrado ML; Landesman SH; Cherubin CE
Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
[TBL] [Abstract][Full Text] [Related]
26. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
Petit JC; Richard G; Burghoffer B; Daguet GL
Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
Høiby N; Bremmelgaard A; Schouenborg P
Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
Greenberg RN; Bollinger MR; Alivisatos MR
Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
[TBL] [Abstract][Full Text] [Related]
29. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)].
Courtieu AL; Drugeon HB; Bryskier A; Chung SS; Reynaud A
Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
[TBL] [Abstract][Full Text] [Related]
31. [Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams].
Thabaut A; Meyran M
Pathol Biol (Paris); 1983 May; 31(5):387-91. PubMed ID: 6413939
[TBL] [Abstract][Full Text] [Related]
32. Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa.
Hoogkamp-Korstanje JA; Westerdaal NA
Infection; 1982; 10 Suppl 3():S257-61. PubMed ID: 6818158
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics.
Philippon A
Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346
[TBL] [Abstract][Full Text] [Related]
34. Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli.
Fass RJ
Antimicrob Agents Chemother; 1982 Jun; 21(6):1003-6. PubMed ID: 6810755
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Pusztai-Markos Z; Pranada F
Eur J Clin Microbiol; 1982 Feb; 1(1):49-51. PubMed ID: 6293811
[TBL] [Abstract][Full Text] [Related]
36. Resistant strains of Pseudomonas aeruginosa isolated after exposure to several beta-lactam antibiotics.
Hoekstra JL; de Neeling AJ; van Klingeren V; Stobberingh EE; van Boven CP
Eur J Clin Microbiol; 1987 Feb; 6(1):22-7. PubMed ID: 3106033
[TBL] [Abstract][Full Text] [Related]
37. Study of in vitro antibacterial activity of 19 antimicrobial agents against Pseudomonas aeruginosa.
Wang R; Sun XD; Cai QM
Chin Med J (Engl); 1989 Apr; 102(4):313-8. PubMed ID: 2507247
[TBL] [Abstract][Full Text] [Related]
38. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT
J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279
[TBL] [Abstract][Full Text] [Related]
39. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases].
Avril JL; Cayla AM; Guist'hau O; Moillo-Batt A
Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345
[TBL] [Abstract][Full Text] [Related]
40. Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.
Gwynn MN; Rolinson GN
Infection; 1980; 8(2):73-80. PubMed ID: 6771215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
